Toward Translation of Nanotechnology Cancer Interventions (TTNCI; R01 Clinical Trial Not Allowed)
Through this Notice of Funding Opportunity (NOFO), entitled "Toward Translation of Nanotechnology Cancer Interventions" (TTNCI), the National Cancer Institute (NCI) encourages applications for advanced pre-clinical research, supporting translation of nanotechnology-based cancer diagnostics and therapeutics. TTNCI awards are designed to mature experimental nanomedicines relying on nanoparticles and nano-devices which demonstrate strong potential to improve cancer treatment effectiveness due to the combination of nanoparticle/nano-device structural design and/or therapeutic/diagnostic cargo which is delivered. TTNCI awards are expected to enable further development of proposed nanotechnology-based interventions to the stage in which they could continue on a developmental path towards the NCI Experimental Therapeutics (NExT) and other NCI translational programs.
Cronologia delle modifiche
First seen 28 Sept 2026, last checked 22 Nov 2026. 20 recorded versions.
- 22 Oct 2026 · 461608169074
- 22 Oct 2026 · 5434ebc5dac6
- 21 Oct 2026 · 6bc329d7e6a3
- 20 Oct 2026 · fea17e0f5b53
- 19 Oct 2026 · ecf5736952a6
- 18 Oct 2026 · 9f1d4e2d6a9b
- 17 Oct 2026 · 66807ae7e23a
- 16 Oct 2026 · 386b1a5b0579
- 15 Oct 2026 · c5b9f731b313
- 14 Oct 2026 · 5d992c7c36f2
- 13 Oct 2026 · a9084f90d3a9
- 12 Oct 2026 · 6db642fabfbb
- 11 Oct 2026 · facfc746590d
- 10 Oct 2026 · cfdaeea32a61
- 09 Oct 2026 · 2efc240ee40b
- 08 Oct 2026 · 13d2246f5a23
- 07 Oct 2026 · 74c0443e2307
- 06 Oct 2026 · c1769531a687
- 05 Oct 2026 · 3c69ad0b9301
- 04 Oct 2026 · 1cec8f25e5d8